| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
International trial of the Edmonton protocol for islet transplantation.
|
N Engl J Med
|
2006
|
13.43
|
|
2
|
Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets.
|
Blood
|
2005
|
2.39
|
|
3
|
Islet transplantation is associated with improvement of renal function among uremic patients with type I diabetes mellitus and kidney transplants.
|
J Am Soc Nephrol
|
2003
|
1.85
|
|
4
|
Human pancreatic islets produce and secrete MCP-1/CCL2: relevance in human islet transplantation.
|
Diabetes
|
2002
|
1.84
|
|
5
|
Islet transplantation in patients with autoimmune diabetes induces homeostatic cytokines that expand autoreactive memory T cells.
|
J Clin Invest
|
2008
|
1.73
|
|
6
|
The glial glutamate transporter 1 (GLT1) is expressed by pancreatic beta-cells and prevents glutamate-induced beta-cell death.
|
J Biol Chem
|
2011
|
1.72
|
|
7
|
Acylated and unacylated ghrelin promote proliferation and inhibit apoptosis of pancreatic beta-cells and human islets: involvement of 3',5'-cyclic adenosine monophosphate/protein kinase A, extracellular signal-regulated kinase 1/2, and phosphatidyl inositol 3-Kinase/Akt signaling.
|
Endocrinology
|
2006
|
1.43
|
|
8
|
Kidney function after islet transplant alone in type 1 diabetes: impact of immunosuppressive therapy on progression of diabetic nephropathy.
|
Diabetes Care
|
2007
|
1.34
|
|
9
|
Requirements for success in clinical islet transplantation.
|
Transplantation
|
2005
|
1.11
|
|
10
|
Chronic hyperglycemia impairs insulin secretion by affecting insulin receptor expression, splicing, and signaling in RIN beta cell line and human islets of Langerhans.
|
FASEB J
|
2003
|
0.98
|
|
11
|
Transplant estimated function: a simple index to evaluate beta-cell secretion after islet transplantation.
|
Diabetes Care
|
2007
|
0.98
|
|
12
|
Long-term beneficial effect of islet transplantation on diabetic macro-/microangiopathy in type 1 diabetic kidney-transplanted patients.
|
Diabetes Care
|
2003
|
0.97
|
|
13
|
Technique, complications, and therapeutic efficacy of percutaneous transplantation of human pancreatic islet cells in type 1 diabetes: the role of US.
|
Radiology
|
2004
|
0.96
|
|
14
|
Islet transplantation improves vascular diabetic complications in patients with diabetes who underwent kidney transplantation: a comparison between kidney-pancreas and kidney-alone transplantation.
|
Transplantation
|
2003
|
0.92
|
|
15
|
Characterization of collagenase blend enzymes for human islet transplantation.
|
Transplantation
|
2007
|
0.91
|
|
16
|
Transglutaminase 2 transamidation activity during first-phase insulin secretion: natural substrates in INS-1E.
|
Acta Diabetol
|
2012
|
0.85
|
|
17
|
Disproportionate hyperproinsulinemia, beta-cell restricted prohormone convertase 2 deficiency, and cell cycle inhibitors expression by human islets transplanted into athymic nude mice: insights into nonimmune-mediated mechanisms of delayed islet graft failure.
|
Cell Transplant
|
2008
|
0.85
|
|
18
|
Minimal focal steatosis of liver after islet transplantation in humans: a long-term study.
|
Cell Transplant
|
2005
|
0.84
|
|
19
|
Prolonged islet allograft survival in diabetic mice upon macrophage depletion by clodronate-loaded erythrocytes.
|
Transplantation
|
2008
|
0.81
|
|
20
|
Diabetes mellitus: an opportunity for therapy with stem cells?
|
Regen Med
|
2008
|
0.81
|
|
21
|
Uric acid may inhibit glucose-induced insulin secretion via binding to an essential arginine residue in rat pancreatic beta-cells.
|
Bioorg Med Chem Lett
|
2005
|
0.81
|
|
22
|
Serological Proteome Analysis (SERPA) as a tool for the identification of new candidate autoantigens in type 1 diabetes.
|
J Proteomics
|
2013
|
0.80
|
|
23
|
Iatrogenic hypoglycemia secondary to tight glucose control is an independent determinant for mortality and cardiac morbidity.
|
Eur J Cardiothorac Surg
|
2011
|
0.80
|
|
24
|
Antitumorigenic and antiinsulinogenic effects of calcitriol on insulinoma cells and solid beta-cell tumors.
|
Endocrinology
|
2002
|
0.80
|
|
25
|
Donor and isolation variables associated with human islet monocyte chemoattractant protein-1 release.
|
Transplantation
|
2004
|
0.77
|
|
26
|
Delta cell death in the islet of Langerhans and the progression from normal glucose tolerance to type 2 diabetes in non-human primates (baboon, Papio hamadryas).
|
Diabetologia
|
2015
|
0.77
|
|
27
|
Late sodium current (INaL) in pancreatic β-cells.
|
Pflugers Arch
|
2014
|
0.77
|
|
28
|
Human placental lactogen (hPL-A) activates signaling pathways linked to cell survival and improves insulin secretion in human pancreatic islets.
|
Islets
|
2011
|
0.76
|
|
29
|
Steroid-free immunosuppression in kidney-islet transplantation: a long-term follow-up.
|
Transplantation
|
2002
|
0.75
|
|
30
|
Temporal clustering for blood glucose analysis in the ICU: identification of groups of patients with different risk profile.
|
Stud Health Technol Inform
|
2010
|
0.75
|
|
31
|
Islet Transplantation in Pediatric Patients: Current Indications and Future Perspectives.
|
Endocr Dev
|
2015
|
0.75
|